nⅥ η申 田…

H.N
%0
つllll
1」 ぅ
1口
Oo001n罰 ぜ1怖 /3o`hЧ l17詢 o15怖 り1出 月q謂 1■ N(Breast Cancer)計
Protocol
gni
n■
Protocol I
CMF
3yclophosphamide
(6 cycle)
Vethotrexate
ug
[:'tlgr 1u]t:
u
uyttt n
(rnfiriru'q)
ol
lИ 詢 J」 ■u餅 」群γ/」 n群
iⅥ α01■ :lln
gnlnli
BrC ll
5-FU
AC
Doxorubicin
(4 cycle)
Cyclophosphamide
CAF
Cyclophosphamide
(6 cycle)
Doxorubicin
CBrC12
CBrC13
5-FU
ACx4/Pac x 4
Doxorubicin
CBrC14A/B
Cyclophosphamide
0R
then Paclitaxel
CBrC15 A/B
AC x4/Pac x12wk〔
IC
cycle)
14
Protoc。 12
CM F
脚彫1,゛ 19]Ⅵ 脚
,彫 」彫::Ⅶ ,∩
(:∩
6 cycle)
,3100
働ぜljn)
Docetaxel(02)
Cyclophosphamide
Cyclophosphamide
Nttliot術
ョЧ脚itt」 彫:1,∩ (00il脚 ¬)
5‐
lllN,彫 U彫 ::Ⅵ ini彫 1]u
3yclophosphamide
(6 cycle)
Doxorubicin
BrC22
FU
AC
Doxorubicin
(6 cycle)
Cyclophosphamide
Pac (6 cycle)
Paclitaxel
CBrC24
Cape (6 cycle)
Capecitabine
CBrC25
Doce (6 cycle)
Docetaxel
CBrC26
1825 days
Iamoxifen
CBrH31
5 yrs
Letrozole
VMI
Iamoxifen
CBrH41
Letrozole
VMI
Megestrol Acetate
CBrH44
550 davs
oofl脚 ■
〔
)
nⅥ
Apirom
FU
CAF
Protocol 4
U彫 :50:働
CBrC21
Methotrexate
5‐
Proto1061 3
CBrC17
CBrC23
η
申 田…
Page 1
9/1/2015